30
Participants
Start Date
February 29, 2004
Primary Completion Date
August 24, 2005
Study Completion Date
August 24, 2005
Lanreotide (Autogel formulation)
Michael White Centre Diabetes & Endocrinology, Hull Royal Infirmary, Hull
Department of Endocrinology, The Royal Free Hospital, Hampstead
Dept of Endocrinology, Aberdeen Royal Infirmary, Aberdeen
Department of Medicine, Queen Elizabeth Hospital, Birmingham
Department of Endocrinology, Coventry & Warwickshire Hospital, Coventry
Department of Endocrinology, Leicester Royal Infirmary, Leicester
Department of Endocrinology, Manchester Royal Infirmary, Manchester
The Oxford Centre for Diabetes, Endocrinology and Metabolism, The Churcill Hospital, Oxford
Department of Endocrinology, Royal Hallamshire Hospital, Sheffield
Department of Endocrinology, Sunderland Royal Hospital, Sunderland
Lead Sponsor
Ipsen
INDUSTRY